Thread

No dia 11 de abril de 2020 foi publicado o famigerado "estudo de Manaus", que usou altas doses da molécula ultrapassada Cloroquina e que concluiu que a Hidroxicloroquina não seria segura. O "erro" do estudo está portanto evidente. Durante o estudo, inclusive, morreram mais de 10 pacientes. Na foto, Marcus Lacerda, um dos líderes do "estudo". Aqui estão os signatários do estudo, conforme documento publicado no MedRXIV, cujo link está no fio. Mayla Gabriela Silva Borba, Fernando Fonseca Almeida Val, Vanderson Sousa Sampaio, Marcia Almeida Araújo Alexandre, Gisely Cardoso Melo, Marcelo Brito, Maria Paula Gomes Mourão, José Diego Brito-Sousa, Djane Baía-da-Silva, Marcus Vinitius Farias Guerra, Ludhmila Abrahão Hajjar, Rosemary Costa Pinto, Antonio Alcirley Silva Balieiro, Felipe Gomes Naveca, Mariana Simão Xavier, Alexandre Salomão, André Machado Siqueira, Alexandre Schwarzbolt, Júlio Henrique Rosa Croda, Maurício Lacerda Nogueira, Gustavo Adolfo Sierra Romero, Quique Bassat, Cor Jesus Fontes, Bernardino Cláudio Albuquerque, Cláudio Tadeu Daniel-Ribeiro, Wuelton Marcelo Monteiro, Marcus Vinícius Guimarães Lacerda, CloroCovid-19 Team Observem com atenção quem financiou esse "estudo": This study was funded by the Government of the Amazonas State, Farmanguinhos (Fiocruz), SUFRAMA, CAPES, FAPEAM, and federal funds granted by a coalition of Brazilian senators. Repito aqui: FUNDOS FEDERAIS FORNECIDOS POR UMA COALIZÃO DE SENADORES BRASILEIROS. Chequem depois os agradecimentos. Contribuições: FFAV, GCM, LAH, WMM, MVFG and MVGL conceived the study and developed the protocol with input from MGSB, VSS, RCP, DCBS, MPGM and QB. MGSB, MAAA, AMS, MPGM and MVGL supervised clinical work. GCM and FGN supervised laboratory work. MGSB supervised pharmacy work. VSS, LAH, DCBC, MSX, AS, JHRC, MLN, GASR, CJF, BCA, CTDR and AASB performed data management and analysis. VSS, JDBS, DCBS, AMS, QB, WMM, and MVGL wrote the manuscript with input from all other authors. CloroCovid-19 Team collected all the data. All authors critically read the manuscript and approved the final submitted version. Agradecimentos do estudo: Special thanks to the Brazilian Minister of Health Luiz Henrique Mandetta, to his Secretary of Health Surveillance (SVS) Wanderson Kleber Oliveira, and his Secretary of Science and Technology (SCTIE) Denizar Vianna, for all the remote support, and to Camile Sachetti (DECIT) and Jorge Souza Mendonça, director of Farmanguinhos. AMS and CTDR are fellows from Fundação de Apoio à Pesquisa do Estado do Rio de Janeiro (FAPERJ). FGN, JHRC, MLN, CTDR, WMM and MVGL are research fellows from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Special thanks to the director of Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, José Luiz Gasparini, to the Governor of the Amazonas State, Wilson Lima, and to his Secretary of Health, Rodrigo Tobias, and Brazilian Senators Eduardo Braga and Eduardo Gomes. To the dean of Universidade do Estado do Amazonas, Cleinaldo Costa, for providing high-quality locally-produced personal protective equipment to the team. To the many industries from the Industrial Pole in Manaus (Zona Franca de Manaus), which donated tablet computers to the team for data collection at bedside, including business executives Wilson Périco and Marcelo Dutra. Many members from the CloroCovid-19 Team are funded by Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM) and CAPES. To ISGlobal, which receives support from the Spanish Ministry of Science and Innovation through Centro de Excelencia Severo Ochoa 2019-2023 Program (CEX2018-000806-S), and support from Generalitat de Catalunya through the CERCA Program. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID). We also thank Judith Recht and Donald Skillman for their thoughtful input on manuscript preparation.